FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2159172854> ?p ?o ?g. }

• W2159172854 abstract "Abstract Background Vinblastine (VBL) is the standard treatment for systemic Langerhans cell histiocytosis (LCH), but little is known about its efficacy in central nervous system (CNS) mass lesions. Methods A retrospective chart review was conducted. Twenty patients from the French LCH Study Group register met the inclusion criteria. In brief, they had CNS mass lesions, had been treated with VBL, and were evaluable for radiologic response. Results The median age at diagnosis of LCH was 11.5 years (range: 1-50). Intravenous VBL 6 mg/m 2 was given in a 6-week induction treatment, followed by a maintenance treatment. The median total duration was 12 months (range: 3-30). Eleven patients received steroids concomitantly. Fifteen patients achieved an objective response; five had a complete response (CR: 25%), ten had a partial response (PR: 50%), four had stable disease (SD: 20%) and one patient progressed (PD: 5%). Of interest, four out of the six patients who received VBL without concomitant steroids achieved an objective response. With a median follow-up of 6.8 years, the 5-year event-free and overall survival was 61% and 84%, respectively. VBL was well-tolerated and there were no patient withdrawals due to adverse events. Conclusion VBL, with or without steroids, could potentially be a useful therapeutic option in LCH with CNS mass lesions, especially for those with inoperable lesions or multiple lesions. Prospective clinical trials are warranted for the evaluation of VBL in this indication." @default.
• W2159172854 created "2016-06-24" @default.
• W2159172854 creator A5003392643 @default.
• W2159172854 creator A5003475412 @default.
• W2159172854 creator A5003732905 @default.
• W2159172854 creator A5011185863 @default.
• W2159172854 creator A5011267190 @default.
• W2159172854 creator A5014436142 @default.
• W2159172854 creator A5015090277 @default.
• W2159172854 creator A5015163256 @default.
• W2159172854 creator A5018906424 @default.
• W2159172854 creator A5028165177 @default.
• W2159172854 creator A5028592793 @default.
• W2159172854 creator A5029042248 @default.
• W2159172854 creator A5029547694 @default.
• W2159172854 creator A5039972816 @default.
• W2159172854 creator A5040751249 @default.
• W2159172854 creator A5048325273 @default.
• W2159172854 creator A5049198404 @default.
• W2159172854 creator A5049627824 @default.
• W2159172854 creator A5052925151 @default.
• W2159172854 creator A5056331856 @default.
• W2159172854 creator A5060235412 @default.
• W2159172854 creator A5068741704 @default.
• W2159172854 creator A5070988285 @default.
• W2159172854 creator A5071345682 @default.
• W2159172854 creator A5075595989 @default.
• W2159172854 creator A5076537402 @default.
• W2159172854 creator A5077054564 @default.
• W2159172854 creator A5079746002 @default.
• W2159172854 creator A5080881858 @default.
• W2159172854 creator A5085752257 @default.
• W2159172854 date "2011-12-01" @default.
• W2159172854 modified "2023-10-16" @default.
• W2159172854 title "Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study" @default.
• W2159172854 cites W1500636739 @default.
• W2159172854 cites W1907977147 @default.
• W2159172854 cites W1959628099 @default.
• W2159172854 cites W1965014389 @default.
• W2159172854 cites W1969038659 @default.
• W2159172854 cites W1975121606 @default.
• W2159172854 cites W1994502045 @default.
• W2159172854 cites W2012481880 @default.
• W2159172854 cites W2013714862 @default.
• W2159172854 cites W2027889680 @default.
• W2159172854 cites W2037618016 @default.
• W2159172854 cites W2039860177 @default.
• W2159172854 cites W2050158629 @default.
• W2159172854 cites W2055014794 @default.
• W2159172854 cites W2072254771 @default.
• W2159172854 cites W2073663272 @default.
• W2159172854 cites W2091364998 @default.
• W2159172854 cites W2095618153 @default.
• W2159172854 cites W2107166045 @default.
• W2159172854 cites W2154417279 @default.
• W2159172854 cites W2160649070 @default.
• W2159172854 cites W2258590390 @default.
• W2159172854 cites W31990271 @default.
• W2159172854 cites W4237223807 @default.
• W2159172854 doi "https://doi.org/10.1186/1750-1172-6-83" @default.
• W2159172854 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3287163" @default.
• W2159172854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22151964" @default.
• W2159172854 hasPublicationYear "2011" @default.
• W2159172854 type Work @default.
• W2159172854 sameAs 2159172854 @default.
• W2159172854 citedByCount "46" @default.
• W2159172854 countsByYear W21591728542012 @default.
• W2159172854 countsByYear W21591728542013 @default.
• W2159172854 countsByYear W21591728542014 @default.
• W2159172854 countsByYear W21591728542015 @default.
• W2159172854 countsByYear W21591728542016 @default.
• W2159172854 countsByYear W21591728542017 @default.
• W2159172854 countsByYear W21591728542018 @default.
• W2159172854 countsByYear W21591728542019 @default.
• W2159172854 countsByYear W21591728542020 @default.
• W2159172854 countsByYear W21591728542021 @default.
• W2159172854 countsByYear W21591728542022 @default.
• W2159172854 countsByYear W21591728542023 @default.
• W2159172854 crossrefType "journal-article" @default.
• W2159172854 hasAuthorship W2159172854A5003392643 @default.
• W2159172854 hasAuthorship W2159172854A5003475412 @default.
• W2159172854 hasAuthorship W2159172854A5003732905 @default.
• W2159172854 hasAuthorship W2159172854A5011185863 @default.
• W2159172854 hasAuthorship W2159172854A5011267190 @default.
• W2159172854 hasAuthorship W2159172854A5014436142 @default.
• W2159172854 hasAuthorship W2159172854A5015090277 @default.
• W2159172854 hasAuthorship W2159172854A5015163256 @default.
• W2159172854 hasAuthorship W2159172854A5018906424 @default.
• W2159172854 hasAuthorship W2159172854A5028165177 @default.
• W2159172854 hasAuthorship W2159172854A5028592793 @default.
• W2159172854 hasAuthorship W2159172854A5029042248 @default.
• W2159172854 hasAuthorship W2159172854A5029547694 @default.
• W2159172854 hasAuthorship W2159172854A5039972816 @default.
• W2159172854 hasAuthorship W2159172854A5040751249 @default.
• W2159172854 hasAuthorship W2159172854A5048325273 @default.
• W2159172854 hasAuthorship W2159172854A5049198404 @default.
• W2159172854 hasAuthorship W2159172854A5049627824 @default.
• W2159172854 hasAuthorship W2159172854A5052925151 @default.
• W2159172854 hasAuthorship W2159172854A5056331856 @default.
• W2159172854 hasAuthorship W2159172854A5060235412 @default.

• next